Deblina Raychaudhuri

2.0k total citations · 2 hit papers
17 papers, 1.2k citations indexed

About

Deblina Raychaudhuri is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Deblina Raychaudhuri has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Deblina Raychaudhuri's work include Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (5 papers) and Immune Response and Inflammation (4 papers). Deblina Raychaudhuri is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (5 papers) and Immune Response and Inflammation (4 papers). Deblina Raychaudhuri collaborates with scholars based in India, United States and Germany. Deblina Raychaudhuri's co-authors include Sangeeta Goswami, Padmanee Sharma, Swetha Anandhan, Pratishtha Singh, Candice C. Poon, Dipyaman Ganguly, Bilal A. Siddiqui, Moran Amit, James P. Allison and Kristal L. Gant and has published in prestigious journals such as Cell, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Deblina Raychaudhuri

15 papers receiving 1.2k citations

Hit Papers

Immune checkpoint therapy—current perspectives and future... 2023 2026 2024 2025 2023 2024 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immune checkpoint therapy—current perspectives and future directions
    2023 579 citations Padmanee Sharma, Sangeeta Goswami et al. Cell profile →
  2. Histone lactylation drives CD8+ T cell metabolism and function
    2024 74 citations Deblina Raychaudhuri, Pratishtha Singh et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deblina Raychaudhuri India 11 604 461 408 173 132 17 1.2k
Monther Al‐Alwan Saudi Arabia 22 840 1.4× 823 1.8× 626 1.5× 217 1.3× 156 1.2× 46 1.8k
Donata Simińska Poland 11 385 0.6× 345 0.7× 439 1.1× 281 1.6× 187 1.4× 19 1.2k
Weina Yu China 12 449 0.7× 411 0.9× 511 1.3× 294 1.7× 165 1.3× 20 1.2k
Mahdi Abdoli Shadbad Iran 22 454 0.8× 569 1.2× 558 1.4× 339 2.0× 167 1.3× 60 1.3k
Turid Hellevik Norway 19 329 0.5× 631 1.4× 524 1.3× 267 1.5× 169 1.3× 26 1.4k
Elise Alspach United States 14 856 1.4× 679 1.5× 632 1.5× 210 1.2× 147 1.1× 19 1.7k
Sandra Pinton Switzerland 15 407 0.7× 405 0.9× 685 1.7× 237 1.4× 232 1.8× 24 1.3k
Dominique Cathelin France 14 881 1.5× 591 1.3× 367 0.9× 104 0.6× 86 0.7× 17 1.4k
Ethel R. Pereira United States 13 282 0.5× 526 1.1× 398 1.0× 236 1.4× 150 1.1× 17 1.1k
Máté Kiss Hungary 14 709 1.2× 442 1.0× 407 1.0× 103 0.6× 71 0.5× 23 1.2k

Countries citing papers authored by Deblina Raychaudhuri

Since Specialization
Citations

This map shows the geographic impact of Deblina Raychaudhuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deblina Raychaudhuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deblina Raychaudhuri more than expected).

Fields of papers citing papers by Deblina Raychaudhuri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deblina Raychaudhuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deblina Raychaudhuri. The network helps show where Deblina Raychaudhuri may publish in the future.

Co-authorship network of co-authors of Deblina Raychaudhuri

This figure shows the co-authorship network connecting the top 25 collaborators of Deblina Raychaudhuri. A scholar is included among the top collaborators of Deblina Raychaudhuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deblina Raychaudhuri. Deblina Raychaudhuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Singh, Pratishtha, Ranit D’Rozario, Deblina Raychaudhuri, et al.. (2026). Loss of KDM6A-mediated genomic instability and metabolic reprogramming regulates response to therapeutic perturbations in bladder cancer. Nature Communications. 17(1). 1382–1382.
2.
Raychaudhuri, Deblina, et al.. (2025). Androgen receptor plays critical role in regulating cervical cancer cell migration. Molecular and Cellular Endocrinology. 606. 112583–112583.
3.
Raychaudhuri, Deblina, et al.. (2024). Histone lactylation drives CD8+ T cell metabolism and function. Nature Immunology. 25(11). 2140–2151. 74 indexed citations breakdown →
4.
Bandopadhyay, Purbita, Jafar Sarif, Ranit D’Rozario, et al.. (2024). Cutting Edge: ATP13A2 Is an Endolysosomal Regulator of TLR9/7 Activation in Human Plasmacytoid Dendritic Cells. The Journal of Immunology. 213(2). 109–114. 1 indexed citations
5.
Goswami, Sangeeta, Deblina Raychaudhuri, Pratishtha Singh, et al.. (2023). Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade. Nature Cancer. 4(10). 1455–1473. 27 indexed citations
6.
Sharma, Padmanee, Sangeeta Goswami, Deblina Raychaudhuri, et al.. (2023). Immune checkpoint therapy—current perspectives and future directions. Cell. 186(8). 1652–1669. 579 indexed citations breakdown →
7.
D’Rozario, Ranit, Deblina Raychaudhuri, Purbita Bandopadhyay, et al.. (2023). Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19. Viruses. 15(2). 549–549. 6 indexed citations
8.
Goswami, Sangeeta, Swetha Anandhan, Deblina Raychaudhuri, & Padmanee Sharma. (2022). Myeloid cell-targeted therapies for solid tumours. Nature reviews. Immunology. 23(2). 106–120. 107 indexed citations
9.
Raychaudhuri, Deblina, Purbita Bandopadhyay, Ranit D’Rozario, et al.. (2022). Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19. SHILAP Revista de lepidopterología. 6(6). 511–524. 4 indexed citations
10.
Kundu, Biswajit, Deblina Raychaudhuri, Purbita Bandopadhyay, et al.. (2021). Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9. Journal of Medicinal Chemistry. 64(13). 9279–9301. 19 indexed citations
11.
Raychaudhuri, Deblina, et al.. (2020). A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant Antagonist. Journal of Medicinal Chemistry. 63(9). 4776–4789. 21 indexed citations
12.
Rahaman, Oindrila, Chinky Shiu Chen Liu, Deblina Raychaudhuri, et al.. (2019). Cutting Edge: Dysregulated Endocannabinoid-Rheostat for Plasmacytoid Dendritic Cell Activation in a Systemic Lupus Endophenotype. The Journal of Immunology. 202(6). 1674–1679. 12 indexed citations
13.
Raychaudhuri, Deblina, Chinky Shiu Chen Liu, Amrit Raj Ghosh, et al.. (2019). Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells. Frontiers in Immunology. 10. 1878–1878. 134 indexed citations
14.
Raychaudhuri, Deblina, Chinky Shiu Chen Liu, Jafar Sarif, et al.. (2019). Role of Ca2+ in toll-like receptor 9 activation in human plasmacytoid dendritic cells. Cytokine. 125. 154822–154822. 3 indexed citations
15.
Rahaman, Oindrila, Sourav Pal, Amrit Raj Ghosh, et al.. (2018). Activity-guided development of potent and selective toll-like receptor 9 antagonists. European Journal of Medicinal Chemistry. 159. 187–205. 15 indexed citations
16.
Liu, Chinky Shiu Chen, Deblina Raychaudhuri, Yogaditya Chakrabarty, et al.. (2018). Cutting Edge: Piezo1 Mechanosensors Optimize Human T Cell Activation. The Journal of Immunology. 200(4). 1255–1260. 122 indexed citations
17.
Ghosh, Amrit Raj, Shamik Bhattacharya, Titli Nargis, et al.. (2016). Adipose Recruitment and Activation of Plasmacytoid Dendritic Cells Fuel Metaflammation. Diabetes. 65(11). 3440–3452. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monther Al‐Alwan Breakdown of academic impact, for papers by Donata Simińska Breakdown of academic impact, for papers by Weina Yu Breakdown of academic impact, for papers by Mahdi Abdoli Shadbad Breakdown of academic impact, for papers by Turid Hellevik Breakdown of academic impact, for papers by Elise Alspach Breakdown of academic impact, for papers by Sandra Pinton Breakdown of academic impact, for papers by Dominique Cathelin Breakdown of academic impact, for papers by Ethel R. Pereira Breakdown of academic impact, for papers by Máté Kiss
Rankless by CCL
2026